Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N5UA
|
|||
| Former ID |
DPR000037
|
|||
| Drug Name |
Dianicline+rimonabant
|
|||
| Synonyms |
[3H]nemonapride; (2R,3R)-nemonapride; 75272-39-8; CHEBI:64219; C21H26ClN3O2; 93664-94-9
Click to Show/Hide
|
|||
| Drug Type |
Combination drug (Antibody)
|
|||
| Indication | Tobacco dependence [ICD-11: 6C4A.2; ICD-10: F17.2; ICD-9: 305.1] | Terminated | [1] | |
| Company |
Sanofi-Aventis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027143) | |||
| REF 2 | Emerging drugs for the treatment of tobacco dependence. Expert Opin Emerg Drugs. 2009 Mar;14(1):23-32. | |||
| REF 3 | Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. J Neurochem. 2003 Nov;87(3):631-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.